JP2024502175A5 - - Google Patents
Info
- Publication number
- JP2024502175A5 JP2024502175A5 JP2023541658A JP2023541658A JP2024502175A5 JP 2024502175 A5 JP2024502175 A5 JP 2024502175A5 JP 2023541658 A JP2023541658 A JP 2023541658A JP 2023541658 A JP2023541658 A JP 2023541658A JP 2024502175 A5 JP2024502175 A5 JP 2024502175A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- haloalkyl
- alkylene
- groups
- heterocycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163134747P | 2021-01-07 | 2021-01-07 | |
| US63/134,747 | 2021-01-07 | ||
| PCT/CA2022/050016 WO2022147622A1 (en) | 2021-01-07 | 2022-01-07 | Isoindolinone aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502175A JP2024502175A (ja) | 2024-01-17 |
| JP2024502175A5 true JP2024502175A5 (cg-RX-API-DMAC7.html) | 2024-12-10 |
Family
ID=82357069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541658A Pending JP2024502175A (ja) | 2021-01-07 | 2022-01-07 | Nuakキナーゼの阻害剤としてのイソインドリノンアミノピリミジン化合物、その組成物及び使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12643886B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4277902A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024502175A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116940565A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022206470A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3204401A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022147622A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102939283B1 (ko) * | 2022-05-03 | 2026-03-13 | 한국화학연구원 | 5-클로로-2,4-다이아미노피리미딘을 포함하는 키나아제 억제 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물 |
| EP4587423A1 (en) * | 2022-09-12 | 2025-07-23 | MiHKAL GmbH | Novel nootropic prodrugs of phenethylamine |
| KR20240156074A (ko) * | 2023-04-21 | 2024-10-29 | (주)엠디바이오팜 | Hpk1 및 mlk3 저해제 및 이를 함유하는 항암용 조성물 |
| CN116947764B9 (zh) * | 2023-07-13 | 2025-07-25 | 特科罗生物科技(成都)有限公司 | 一种嘧啶胺类nuak抑制剂及其制备方法和用途 |
| KR20250041906A (ko) * | 2023-09-19 | 2025-03-26 | (주)엠디바이오팜 | Hpk1 및 mlk3 저해 활성을 갖는 신규한 화합물 및 이를 함유하는 항암용 조성물 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE542801T1 (de) * | 2003-08-15 | 2012-02-15 | Novartis Ag | Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine |
| US7521457B2 (en) * | 2004-08-20 | 2009-04-21 | Boehringer Ingelheim International Gmbh | Pyrimidines as PLK inhibitors |
| GB0419161D0 (en) * | 2004-08-27 | 2004-09-29 | Novartis Ag | Organic compounds |
| EP1966207A2 (en) | 2005-12-21 | 2008-09-10 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
| MX2009004426A (es) * | 2006-10-23 | 2009-08-12 | Cephalon Inc | Derivados biciclicos fusionados de 2,4-diaminopirimidina como inhibidores alk y c-met. |
| HRP20170317T1 (hr) | 2008-02-15 | 2017-04-21 | Rigel Pharmaceuticals, Inc. | Spojevi pirimidin-2-amina i njihova uporaba kao inhibitora jak kinaza |
| JP2011523646A (ja) * | 2008-05-21 | 2011-08-18 | アリアド・ファーマシューティカルズ・インコーポレイテッド | キナーゼ阻害剤としてのリン誘導体 |
| WO2010090875A1 (en) * | 2009-01-21 | 2010-08-12 | Rigel Pharmaceuticals, Inc. | Derivatives of n2-(3-pyridil or phenyl)-n4-(4-piperidyl)-2,4-pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases |
| CA2788450A1 (en) | 2009-12-30 | 2011-07-07 | Arqule, Inc. | Substituted naphthalenyl-pyrimidine compounds |
| KR20130139999A (ko) | 2010-10-14 | 2013-12-23 | 어리어드 파마슈티칼스, 인코포레이티드 | Egfr-유도된 암의 세포 증식을 억제하는 방법 |
| TWI810172B (zh) * | 2017-01-26 | 2023-08-01 | 南韓商韓美藥品股份有限公司 | 嘧啶化合物及包括其的藥學組成物 |
| US20230096028A1 (en) | 2019-03-01 | 2023-03-30 | Revolution Medicines, Inc. | Bicyclic heterocyclyl compounds and uses thereof |
| HUE065486T2 (hu) | 2019-05-10 | 2024-05-28 | Deciphera Pharmaceuticals Llc | Fenilaminopirimidinamid autophágia inhibitorok és azok felhasználási eljárásai |
| US20230227484A1 (en) * | 2020-05-29 | 2023-07-20 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Pyrimidine compound as axl inhibitor |
-
2022
- 2022-01-07 US US18/271,103 patent/US12643886B2/en active Active
- 2022-01-07 CA CA3204401A patent/CA3204401A1/en active Pending
- 2022-01-07 EP EP22736481.7A patent/EP4277902A4/en not_active Withdrawn
- 2022-01-07 CN CN202280019578.4A patent/CN116940565A/zh active Pending
- 2022-01-07 WO PCT/CA2022/050016 patent/WO2022147622A1/en not_active Ceased
- 2022-01-07 JP JP2023541658A patent/JP2024502175A/ja active Pending
- 2022-01-07 AU AU2022206470A patent/AU2022206470A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025028934A (ja) | ケタミンのプロドラッグ、組成物及びそれらの使用 | |
| ES2707534T3 (es) | Compuestos útiles como inmunomoduladores | |
| JP6824954B2 (ja) | mIDH1阻害剤としての5−ヒドロキシアルキルベンズイミダゾール | |
| JP2022520448A5 (cg-RX-API-DMAC7.html) | ||
| JP2025081607A (ja) | 統合的ストレス経路のプロドラッグ調節剤 | |
| JP2021529812A5 (cg-RX-API-DMAC7.html) | ||
| JP6883049B2 (ja) | アミノチアゾール化合物及びその使用 | |
| ES2675074T3 (es) | Compuestos de aril-fenil-sulfonamida-fenileno y su uso | |
| JP2024530952A5 (cg-RX-API-DMAC7.html) | ||
| JP2014503567A5 (cg-RX-API-DMAC7.html) | ||
| CN112218850A (zh) | 整合应激通路的调节剂 | |
| JP2024502174A5 (cg-RX-API-DMAC7.html) | ||
| TW201808887A (zh) | 整合應激途徑之調節劑 | |
| KR20190041471A (ko) | 케모카인 수용체 조절제 및 이의 용도 | |
| JP6824952B2 (ja) | mIDH1阻害剤としての2−アリール−および2−アリールアルキル−ベンズイミダゾール | |
| PH12014501626B1 (en) | Therapeutically active compounds and their methods of use | |
| US20110178087A1 (en) | Compositions and Their Use as Anti-Tumor Agents | |
| IL279800B1 (en) | Selective allosteric inhibitors of epidermal growth factor receptor mutants, pharmaceutical preparations containing them and their use | |
| RU2006118785A (ru) | Новые нитрофенилипритные и нитрофенилазиридиновые спирты и их соответствующие фосфаты и их применение в качестве нацеленных цитотоксическихих средств | |
| JP2024520630A5 (cg-RX-API-DMAC7.html) | ||
| JP2022550353A5 (cg-RX-API-DMAC7.html) | ||
| JP2017137323A (ja) | 新規抗がん剤 | |
| RU2004104329A (ru) | Ацилсемикарбазиды как ингибиторы циклинзависимой киназы, полезные в качестве противораковых и противопролиферативных агентов | |
| JP2020530479A5 (cg-RX-API-DMAC7.html) | ||
| CN110049768A (zh) | 酚噻嗪衍生物及其使用方法 |